C4A and type III hypersensitivity disease: In the context of a C1-INH deficiency, abnormal activation of complement via the classical pathway consumes the initial components of the cascade and may expose HAE patients to an increased risk of immune-complex disease, as seen in the C2 or C4 deficiencies.